Skip to main content
SpringerLink
Log in
Book cover

Endoscopic Oncology pp 295–302Cite as

Diagnosis and Evaluation of Pancreatic Ductal Adenocarcinoma

  • Chapter

  • 840 Accesses

Abstract

Pancreatic cancer is the fourth most common cause of cancer-related mortality in the United States (1). The 5-yr survival rate is the lowest among all cancers, with estimates ranging from 0.4 to 4%. The only potentially curative treatment for pancreatic cancer is surgical resection. However, because the disease is generally advanced at presentation, only 10–20% of patients are eligible for attempted curative resection. In these patients who undergo pancreaticoduodenectomy, 5-yr survival is somewhat better, about 20% (2). The epidemiology and clinical features of pancreatic cancer will be reviewed. A careful examination of current imaging technology in the staging, diagnosis, and evaluation of pancreatic adenocarcinoma will also be discussed.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995; 76(9): 1671–1677.

    Article  Google Scholar 

  2. Ahrendt SA, Pitt HA. Surgical management of pancreatic cancer. Oncology (Huntington) 2002; 16(6):725–734.

    Google Scholar 

  3. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53(1):5–26.

    PubMed  Google Scholar 

  4. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002; 2(12):897–909.

    Article  PubMed  CAS  Google Scholar 

  5. DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 1999; 117(6):1464–1484.

    Article  Google Scholar 

  6. Hruban RH, Petersen GM, Ha PK, Kern SE. Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am 1998; 7(1):1–23.

    PubMed  CAS  Google Scholar 

  7. Luttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Kloppel G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 1999; 85(8): 1703–1710.

    Article  PubMed  CAS  Google Scholar 

  8. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004; 363(9414):1049–1057.

    Article  PubMed  CAS  Google Scholar 

  9. Bakkevold KE, Arnesjo B, Kambestad B. Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumour site. A prospective multicentre trial in 472 patients. Norwegian Pancreatic Cancer Trial. Scand J Gastroenterol 1992; 27(4):317–325.

    PubMed  CAS  Google Scholar 

  10. Exocrine pancreas. In: Greene FL, Page DL, Fleming DL, et al, eds. American Joint Committee on Cancer: AJCC Cancer Staging Manual. New York: Springer, 2002; 157–164.

    Google Scholar 

  11. Pleskow DK, Berger HJ, Gyves J, Allen E, McLean A, Podolsky DK. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer. Ann Intern Med 1989; 110(9):704–709.

    PubMed  CAS  Google Scholar 

  12. Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am 1994; 8(3):533–553.

    PubMed  CAS  Google Scholar 

  13. Safi F, Schlosser W, Falkenreck S, Beger HG. CA 19-9 serum course and prognosis of pancreatic cancer. Int J Pancreatol 1996; 20(3): 155–161.

    PubMed  CAS  Google Scholar 

  14. Kim HJ, Kim MH, Myung SJ, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999; 94(7):1941–1946.

    Article  PubMed  CAS  Google Scholar 

  15. Permert J, Larsson J, Westermark GT, et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 1994; 330(5):313–318.

    Article  PubMed  CAS  Google Scholar 

  16. Chari ST, Klee GG, Miller LJ, Raimondo M, DiMagno EP. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 2001; 121(3):640–645.

    Article  PubMed  CAS  Google Scholar 

  17. Uemura T, Hibi K, Kaneko T, et al. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients. J Gastroenterol 2004; 39(1):56–60.

    Article  PubMed  CAS  Google Scholar 

  18. Watanabe H, Sawabu N, Ohta H, et al. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn J Cancer Res 1993; 84(9):961–965.

    PubMed  CAS  Google Scholar 

  19. Iguchi H, Sugano K, Fukayama N, et al. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology 1996; 110(1):221–226.

    Article  PubMed  CAS  Google Scholar 

  20. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994; 54(13):3568–3573.

    PubMed  CAS  Google Scholar 

  21. Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190(3):745–751.

    PubMed  CAS  Google Scholar 

  22. Valls C, Andia E, Sanchez A, et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol 2002; 178(4):821–826.

    PubMed  Google Scholar 

  23. Freeny PC, Marks WM, Ryan JA, Traverso LW. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology 1988; 166(1 Part 1):125–133.

    Google Scholar 

  24. Freeny PC, Traverso LW, Ryan JA. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg 1993; 165(5):600–606.

    Article  PubMed  CAS  Google Scholar 

  25. Megibow AJ, Zhou XH, Rotterdam H, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability— report of the Radiology Diagnostic Oncology Group. Radiology 1995; 195(2):327–332.

    PubMed  CAS  Google Scholar 

  26. Bluemke DA, Cameron JL, Hruban RH, et al. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 1995; 197(2):381–385.

    PubMed  CAS  Google Scholar 

  27. Zeman RK, Cooper C, Zeiberg AS, et al. TNM staging of pancreatic carcinoma using helical CT. AJR Am J Roentgenol 1997; 169(2):459–464.

    PubMed  CAS  Google Scholar 

  28. Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M. Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 1998; 206(2):373–378.

    PubMed  CAS  Google Scholar 

  29. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 1997; 168(6):1439–1443.

    PubMed  CAS  Google Scholar 

  30. Roche CJ, Hughes ML, Garvey CJ, et al. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 2003; 180(2):475–480.

    PubMed  Google Scholar 

  31. Gress FG, Hawes RH, Savides TJ, et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 1999; 50(6):786–791.

    Article  PubMed  CAS  Google Scholar 

  32. Akahoshi K, Chijiiwa Y, Nakano I, et al. Diagnosis and staging of pancreatic cancer by endoscopic ultrasound. Br J Radiol 1998; 71(845):492–496.

    PubMed  CAS  Google Scholar 

  33. Baron PL, Aabakken LE, Cole DJ, et al. Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound. Ann Surg Oncol 1997; 4(8):639–643.

    Article  Google Scholar 

  34. Legmann P, Vignaux O, Dousset B, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998; 170(5):1315–1322.

    PubMed  CAS  Google Scholar 

  35. Rosch T, Lorenz R, Braig C, et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 1991; 37(3):347–352.

    PubMed  CAS  Google Scholar 

  36. Snady H, Cooperman A, Siegel J. Endoscopic ultrasonography compared with computed tomography with ERCP in patients with obstructive jaundice or small peri-pancreatic mass. Gastrointest Endosc 1992; 38(1):27–34.

    Article  PubMed  CAS  Google Scholar 

  37. Yasuda K, Mukai H, Fujimoto S, Nakajima M, Kawai K. The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc 1988; 34(1):1–8.

    PubMed  CAS  Google Scholar 

  38. Nakaizumi A, Uehara H, Iishi H, et al. Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer. Dig Dis Sci 1995; 40(3):696–700.

    Article  Google Scholar 

  39. Palazzo L, Roseau G, Gayet B, et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993; 25(2): 143–150.

    PubMed  CAS  Google Scholar 

  40. Gress FG. The role of endoscopic ultrasound in the staging of pancreatic adenocarcinoma. In: Rose BD, editor. UpToDate. Wellesley, MA: 2004.

    Google Scholar 

  41. Yusoff IF, Mendelson RM, Edmunds SE, et al. Preoperative assessment of pancreatic malignancy using endoscopic ultrasound. Abdom Imaging 2003; 28(4):556–562.

    Article  PubMed  CAS  Google Scholar 

  42. Ahmad NA, Lewis JD, Ginsberg GG, Rosato EF, Morris JB, Kochman ML. EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 2000; 52(4):463–468.

    Article  PubMed  CAS  Google Scholar 

  43. Rosch T, Dittler HJ, Strobel KR et al. Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc 2000; 52(4):469–477.

    Article  PubMed  CAS  Google Scholar 

  44. Rosch T, Braig C, Gain T, et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with 302 conventional sonography, computed tomography, and angiography. Gastroenterology 1992; 102(1):188–199.

    PubMed  CAS  Google Scholar 

  45. Soriano A, Castells A, Ayuso C, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 2004; 99(3):492–501.

    Article  PubMed  Google Scholar 

  46. Ahmad NA, Lewis JD, Siegelman ES, Rosato EF, Ginsberg GG, Kochman ML. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma. Am J Gastroenterol 2000; 95(8): 1926–1931.

    Article  PubMed  CAS  Google Scholar 

  47. Varghese JC, Farrell MA, Courtney G, Osborne H, Murray FE, Lee MJ. Role of MR cholangiopancreatography in patients with failed or inadequate ERCP. AJR Am J Roentgenol 1999; 173(6):1527–1533.

    PubMed  CAS  Google Scholar 

  48. Adamek HE, Albert J, Breer H, Weitz M, Schilling D, Riemann JF. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 2000; 356(9225): 190–193.

    Article  PubMed  CAS  Google Scholar 

  49. Friess H, Langhans J, Ebert M, et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut 1995; 36(5):771–777.

    Article  PubMed  CAS  Google Scholar 

  50. Bares R, Klever P, Hauptmann S, et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994; 192(1):79–86.

    PubMed  CAS  Google Scholar 

  51. Kato T, Fukatsu H, Ito K, et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem. Eur J Nucl Med 1995; 22(1):32–39.

    Article  PubMed  CAS  Google Scholar 

  52. Ho CL, Dehdashti F, Griffeth LK, Buse PE, Balfe DM, Siegel BA. FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr 1996; 20(3):363–369.

    Article  PubMed  CAS  Google Scholar 

  53. Zimny M, Bares R, Fass J, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 1997; 24(6):678–682.

    PubMed  CAS  Google Scholar 

  54. Delbeke D, Rose DM, Chapman WC, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 1999; 40(11):1784–1791.

    PubMed  CAS  Google Scholar 

  55. Kasperk RK, Riesener KP, Wilms K, Schumpelick V. Limited value of positron emission tomography in treatment of pancreatic cancer: surgeon’s view. World J Surg 2001; 25(9): 1134–1139.

    PubMed  CAS  Google Scholar 

  56. Frohlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN. Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 1999; 40(2):250–255.

    PubMed  CAS  Google Scholar 

  57. Berberat P, Friess H, Kashiwagi M, Beger HG, Buchler MW. Diagnosis and staging of pancreatic cancer by positron emission tomography. World J Surg 1999; 23(9):882–887.

    Article  PubMed  CAS  Google Scholar 

  58. Bares R, Dohmen BM, Cremerius U, Fass J, Teusch M, Bull U. (Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma). Radiologe 1996; 36(5):435–440.

    Article  PubMed  CAS  Google Scholar 

  59. Koyama K, Okamura T, Kawabe J, et al. Diagnostic usefulness of FDG PET for pancreatic mass lesions. Ann Nucl Med 2001; 15(3):217–224.

    PubMed  CAS  Google Scholar 

  60. Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs percutaneous FNA. Gastrointest Endosc 2003; 58(5):690–695.

    Article  PubMed  Google Scholar 

  61. Ylagan LR, Edmundowicz S, Kasal K, Walsh D, Lu DW. Endoscopic ultrasound guided fine-needle aspiration cytology of pancreatic carcinoma: a 3-year experience and review of the literature. Cancer 2002; 96(6):362–369.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA

    Kenneth H. Yu MD

  2. Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA

    Nuzhat A. Ahmad MD

Authors
  1. Kenneth H. Yu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nuzhat A. Ahmad MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oregon Health and Science University, Portland, OR

    Douglas O. Faigel MD, FACG, FASGE (Associate Professor of Medicine, Director of Endoscopy) (Associate Professor of Medicine, Director of Endoscopy)

  2. Hospital of the University of Pennsylvania, Philadelphia, PA

    Michael L. Kochman MD, FACP, FASGE (Professor of Medicine and Surgery, Co-Director Gastrointestinal Oncology) (Professor of Medicine and Surgery, Co-Director Gastrointestinal Oncology)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Yu, K.H., Ahmad, N.A. (2006). Diagnosis and Evaluation of Pancreatic Ductal Adenocarcinoma. In: Faigel, D.O., Kochman, M.L. (eds) Endoscopic Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-172-7_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-172-7_25

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-532-3

  • Online ISBN: 978-1-59745-172-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation